West Nile Virus M glycoprotein肽(ab39904)

概述

  • 产品名称West Nile Virus M glycoprotein肽

描述

  • 性质Synthetic

技术指标

Our Abpromise guarantee covers the use of ab39904 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • 应用

    Blocking

    ELISA

  • 形式Liquid
  • Concentration information loading...

制备和贮存

  • 稳定性和存储

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

    Preservative: 0.02% Sodium Azide
    Constituents: 0.1% BSA, PBS, pH 7.2

常规信息

  • 别名
    • Envelope protein M
    • Matrix protein
    • West Nile virus matrix protein
    • WNV matrix protein
  • 相关性West Nile (WN), the most widespread among flaviviruses, was first isolated from the serum of a febrile woman in 1937 in the West Nile district of Uganda. West Nile virus was first detected in North America in 1999 and has subsequently spread throughout the United States and Canada and into Mexico and the Caribbean. In Africa, southern Europe, western Asia, and the United States, WNV has been isolated from mosquitoes of more than 40 species. In the United States, Canada, and Israel, WNV is responsible for significant avian mortality.

West Nile Virus M glycoprotein peptide (ab39904)参考文献

ab39904 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab39904.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"